REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Skinfarma S A S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Skinfarma S A S Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Skinfarma S A S is primarily engaged in drugs and druggists' sundries merchant wholesalers and related activities. It's been operating in the Colombian market since 2009.

Headquarters
Calle 116 N 9 - 58
Bogota D.C.; Bogota D.C; Postal Code: 1002

Contact Details: Purchase the Skinfarma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Skinfarma S A S report to view the information.
Outstanding Shares:
Purchase the Skinfarma S A S report to view the information.
Incorporation Date:
September 01, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Skinfarma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-85.63%▼
Total operating revenue
-85.63%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-1183.4%▼
Total assets
-78.88%▼
Total equity
-97.96%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-243.65%▼
Return on Equity (ROE)
-5567.01%▼
Quick Ratio
0.48%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo